Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Cardiology
•
Interventional Cardiology
What techniques do you use in the lab to reduce the amount of contrast that needs to be used in patients with CKD?
Answer from: at Academic Institution
Avoid LV angiogram. Use ECHO instead to assess LV function.
Sign In
or
Register
to read more
Answer from: at Academic Institution
Reducing Fr size Limited views Using co-registration tools Occasional addition of an NS mix
Comments
at Cardiology Associates Of Fairfield County
Using IVUS can also be helpful instead of taking m...
at Johns Hopkins University
Here's a summary! assist injection device cons...
12387
12413
Sign In
or
Register
to read more
24167
23057
Related Questions
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
What is your preferred duration of aggrastat therapy, and does it differ if patient presented with NSTEMI versus STEMI?
What is your systolic blood pressure target for patients over 80 with frailty and multiple comorbidities?
What has been your approach to minimizing the risk of vascular complications when placing Impella support devices?
What are some immunosuppression regimens to consider in a patient with refractory cardiac sarcoidosis?
Do you recommend stepwise de-escalation of dual antiplatelet therapy for patients at high risk of bleeding who have undergone drug-coated balloon angioplasty?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
How do you use NT-proBNP in patients with chronic kidney disease or end-stage kidney disease, given that these conditions can affect NT-proBNP levels?
In light of recent trials evaluating NPO before cath (CHOW NOW, SCOFF, etc.) are centers still restricting oral intake pre-procedure?
How do you consider and approach transition to hospice in a patient with HFrEF who does not appear to tolerate GDMT?